Compassionate use of investigational new drugs: is the current process effective? : hearing before the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, June 20, 2001
U.S. G.P.O., 2002 - Medical - 150 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Hearing held on June 20 2001 1
Letters statements etc submitted for the record
Other editions - View all
Abigail access to experimental Ann Davis approval process AstraZenica Barr Baxter breast cancer Burroughs Burton cancer patients Chairman chemo chemotherapy clinical trials colon cancer colorectal cancer Committee compassionate use program David David's doctor Davis of Virginia Delaney diagnosed disease drug available drug companies drug development early access programs effect efficacy experimental drugs experimental treatments facility FDA approval FDA's formulated prognosis frank disclosure give going Government Reform head and neck hearing hope hospice ImClone Systems important investigational drugs IRESSA issue Kellum life-threatening live manufacturing months Morella mother neck cancer needs oncologist oncology Orphan Drug OSI Pharmaceuticals pharmaceutical companies phase physicians protocol question requests safety Samuel Waksal Santino single patient IND sponsor surgery talking tell Temple terminally ill testimony Thank things tients treated treatment IND treatment options tumor Waksal Weldon wife